ACE and diabetes mellitus: Adjusted for age, sex, diabetes, and coronary artery disease, use of a beta‐blocker therapy (P=0.04) and angiotensin‐converting enzyme inhibitor or receptor blocker (P=0.03) was associated with better survival.